Free Trial
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
HEALTHCARE
- Roche trades tight in EUR vs USD (see Graph for X-CCY analysis) nevertheless they are bringing a triple tranche deal in $ today.
- Roche acquired Telavant for $7.1b in Oct ’23 and Carmot for $2.7b in Dec ’23
- Excluding today’s issuance, they will have issued $9.375b and €3b since Nov ’23 which more than covers M&A’s immediate needs.
- They shouldn’t need to come in Euro any time soon but it is surprising that they are coming in $ given the strength of the EUR market currently and relative value.
Source: MNI, Bloomberg
Why MNI
MNI is the leading provider
of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
We are facing technical issues, please contact our team.
ok
Your request was sent sucessfully! Our team will contact you soon.
ok